BIOVOX provides for healthcare applications. Maximum patient safety, regulatory compliance & sustainability from renewable feedstocks.
BIOVOX has raised $2.4M in total funding. The most recent round was Seed. The last funding was announced in September 2024.
BIOVOX's investors include HTGF (High-Tech Gruenderfonds), Auxxo, better ventures, BM H Beteiligungs-Managementgesellschaft Hessen, Anne Lemcke.
BIOVOX is headquartered in Darmstadt, Germany.
BIOVOX provides for healthcare applications. Maximum patient safety, regulatory compliance & sustainability from renewable feedstocks.
BIOVOX is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"BIOVOX — Funding & Investors." VCBacked, September 25, 2024, https://www.vcbacked.co/company/biovox. Accessed August 13, 2026.
VCBacked. (2024). BIOVOX — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/biovox
{{cite web |title=BIOVOX — Funding & Investors |url=https://www.vcbacked.co/company/biovox |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated